When incubated with ATP molecules, GroEL exhibited a rapid dox release profile in vitro, while in vivo anti-tumor experiments also indicated that this ATP-responsive delivery system could efficiently inhibit tumor growth (Yuan et al., 2018). The gene discussed is HSPD1; the disease is neoplasm.